Harvard Bioscience
(HBIO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,789 | 4,508 | 5,144 | 4,259 | 5,433 |
| Receivables | 17,737 | 16,705 | 15,023 | 17,847 | 20,274 |
| Inventories | 26,861 | 26,439 | 26,116 | 29,336 | 28,711 |
| Other current assets | 4,062 | 3,472 | 5,535 | 5,056 | 5,030 |
| TOTAL | $52,449 | $51,124 | $51,818 | $56,498 | $59,448 |
| Non-Current Assets | |||||
| PPE Net | 3,424 | 3,366 | 3,555 | 3,394 | 3,499 |
| Intangibles | 76,259 | 77,274 | 77,315 | 80,451 | 83,234 |
| Other Non-Current Assets | 13,446 | 13,596 | 14,325 | 14,930 | 11,863 |
| TOTAL | $93,129 | $94,236 | $95,195 | $98,775 | $98,596 |
| Total Assets | $145,578 | $145,360 | $147,013 | $155,273 | $158,044 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,970 | 3,811 | 2,720 | 2,720 | 2,720 |
| Accounts payable and accrued liabilities | 5,978 | 6,447 | 5,877 | 6,810 | 6,218 |
| Other current liabilities | 8,018 | 10,856 | 7,000 | 8,104 | 12,181 |
| TOTAL | $23,217 | $23,249 | $21,360 | $23,354 | $27,226 |
| Non-Current Liabilities | |||||
| Long Term Debt | 41,083 | 43,013 | 46,534 | 45,764 | 46,244 |
| Deferred Revenues | 4,121 | N/A | 3,642 | 3,612 | 3,956 |
| Other Non-Current Liabilities | 6,392 | 6,288 | 5,959 | 6,224 | 6,757 |
| TOTAL | $48,021 | $49,891 | $53,674 | $54,415 | $54,443 |
| Total Liabilities | $71,238 | $73,140 | $75,034 | $77,769 | $81,669 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 42,190 | 42,190 | 41,658 | 41,637 | 41,241 |
| Common Shares | 455 | 454 | 453 | 453 | 452 |
| Retained earnings | -141,568 | -142,190 | -140,524 | -137,119 | -139,554 |
| Other shareholders' equity | -14,655 | -15,052 | -16,179 | -13,243 | -10,726 |
| TOTAL | $74,340 | $72,220 | $71,979 | $77,504 | $76,375 |
| Total Liabilities And Equity | $145,578 | $145,360 | $147,013 | $155,273 | $158,044 |